What Happens When a Drug Is Recalled?
The FDA’s drug recall system is meant to protect consumers, but inspection blind spots, manufacturing lapses, and slow communication can leave dangerous medications in circulation for months
Aug 27, 2025Menu
Shedding Light on the Risks
& Benefits of Medications
Shedding Light on the Risks
& Benefits of Medications Drug Safety
The FDA’s Drug Adverse Event Database Is Now Updated in Real Time: Here’s How to Use It
Updates to the FDA’s Adverse Events Reporting System (FAERS) will be more frequent, but they don’t tell the whole story
Aug 25, 2025
When Insurance Makes You Try Cheaper Drugs First
The policy, known as step therapy, requires some patients to try lower-cost medications before insurers approve the treatment their doctor prescribed
Jul 21, 2025
Why Pharmacies Are Disappearing, And What We Lose When They Do
Pharmacists are vital to the safety of our medications and health system. But with rising staff burnout and pharmacy closures, the profession is in crisis
Jun 24, 2025
Medical Journals Have Flaws, But Government Oversight Isn’t the Fix
Peer review isn’t perfect, but it was designed to guard against government overreach, something Kennedy’s plan threatens to undo
Jun 13, 2025
Unannounced Inspections of Drug Manufacturers Could Improve Drug Safety — If It Actually Happens
In May, President Trump issued an executive order directing the FDA to conduct more surprise inspections of overseas drug manufacturing labs — a practice already underway but long hampered by logistical and diplomatic challenges
Jun 10, 2025
Controlled Drug Classifications: Schedule I, II, III, IV, V
How the DEA classifies these drugs based on medical value and misuse potential — and why some experts say the system needs a second look
May 8, 2025
Mission Critical Update: Medication Safety Updates from the FDA Delayed
FDA drug safety updates have stalled amid new administration decisions, raising concerns about delayed warnings and public transparency
Apr 24, 2025
Makary’s “Blind Spots” Offers Big Ideas — But Can He Deliver as FDA Commissioner?
In his book, Marty Makary makes a convincing case for challenging medical dogma. But will he be able to turn that vision into a reality at the FDA?
Apr 11, 2025
Journavx: How Safe Is This New FDA-Approved Painkiller?
Journavx works differently from opioids and may have a lower risk of addiction, but with limited clinical trial data, much about the drug remains unknown
Mar 17, 2025
Opinion: RFK’s “Radical Transparency” Looks More Like A Closed Door
Despite promises to the contrary, recent actions by RFK Jr. and the new administration are stripping away public oversight concerning our nation’s healthcare
Mar 13, 2025
Medication Safety For Older Adults: Strategies To Reduce Risk And Improve Care
With medication errors and polypharmacy putting older adults at risk, experts call for new strategies—from caregiver support to rethinking prescriptions—to improve safety
Mar 12, 2025
The FDA’s New Drug Ad Rules Are Here. Will They Actually Change Anything?
The FDA has introduced new guidelines to enhance the transparency of drug commercials, aiming to protect consumers. But are these changes really making a difference?
Mar 3, 2025
Opinion: Transforming U.S. Drug Policy for Better Drug Safety
With key health agencies under new leadership, there are real, concrete ways to reform drug safety and accountability to protect all Americans.
Feb 25, 2025
Effexor’s Link To Dangerous Spikes In Blood Pressure
While more commonly associated with mild blood pressure increases, the drug can sometimes lead to a sudden hypertensive crisis, even months after starting treatment.
Feb 19, 2025
How Safe is Veozah? The FDA-Approved Hot Flash Treatment
A new black box warning has been issued for a rare but serious risk of liver damage
Dec 18, 2024
Inside the FDA Drug Development Process: The Limits of Clinical Trials in Preventing Side Effects
Discover how the FDA clinical trial process works and what its limitations mean for your safety and the effectiveness of drugs in everyday use
Dec 13, 2024
Opinion: FDA Proposes Removing Sudafed PE and Cold Meds
An advisory committee unanimously decided that oral phenylephrine was ineffective a year ago. But Americans are still buying it
Nov 21, 2024
What To Know About Cobenfy, First New FDA-Approved Treatment For Schizophrenia in Decades
Cobenfy represents an answer to significant side effects from older antipsychotics—but long-term clinical testing on humans is lacking
Sep 30, 2024
6 Drugs That Can Cause Kidney Damage
Common OTC and prescription drugs can lead to kidney damage—here’s what you need to know to keep your kidneys safe.
Aug 7, 2024
WEBINARS
Stream our library on demand, including insights on generic drugs and pain management, straight from experts.
WATCH NOW